Qvt Financial LP Agenus Inc Transaction History

Qvt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $2.34 Million - $3.56 Million	-1,469,534 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $3.45 Million - $7.1 Million	-1,526,296 Reduced 50.95%	1,469,534 $3.23 Million
Q1 2018 May 15, 2018	SELL	$3.51 - $6.04 $721,069 - $1.24 Million	-205,433 Reduced 6.42%	2,995,830 $13.2 Million
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $872,255 - $1.28 Million	-267,563 Reduced 7.71%	3,201,263 $9.79 Million
Q3 2017 Nov 14, 2017	BUY	$3.48 - $4.44 $12.1 Million - $15.4 Million	3,468,826	3,468,826 $15.3 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Qvt Financial LP with notifications on news.